Explore the evolving regulatory landscape shaping the intersection of artificial intelligence and healthcare across enterprises. This session dives into key regulations like HTI-2, Lab Developed Tests (LDTs), Section 1557 for AI/DEI, and the implications of the “CDS dead?” debate. Gain insights into how these regulations impact diagnostic workflows, enterprise imaging strategies, and the future of AI-driven healthcare innovation. Attendees will leave equipped with the knowledge to navigate compliance challenges while leveraging AI to drive advancements across specialties.

Objectives

• Compare the current regulatory requirements (HTI-2, LDTs, Section 1557) and their implications for AI applications across clinical and enterprise imaging workflows.
• Explain the “CDS dead?” debate and its relevance to AI decision support systems in enterprise diagnostics.
• Discuss future regulatory trends and their potential impact on advancing AI adoption across healthcare enterprises.